Ali A. Al-Mubarak

Sep 14, 2023 | nature.com | George Markousis-Mavrogenis |Ali A. Al-Mubarak |Nils Bomer |Adriaan A. Voors |Lukas Baumhove

AbstractThe immune system is intimately involved in the pathophysiology of heart failure. However, it is currently underused as a therapeutic target in the clinical setting. Moreover, the development of novel immunomodulatory therapies and their investigation for the treatment of patients with heart failure are hampered by the fact that currently used, evidence-based treatments for heart failure exert multiple immunomodulatory effects.